Survivors of COVID-19 seek a way to help those suffering, often feeling a sense of obligation. Blood plasma from rehabilitated COVID-19 patients has emerged as a promising treatment option to aid COVID-19 patients fighting for their lives. Those who have recovered from COVID-19 have built up antibodies in their bloodstream that can now follow its path and subsequently neutralize the virus in others. On March 24, the FDA released guidelines as an investigational new therapy whereby a recovered patient would donate his or her blood plasma in a process typical of an ordinary blood donation. “With few treatments available for COVID-19 patients, Agudath Israel of America was eager to explore options and see what could be done to help the many suffering,” says Avrohom Weinstock, Chief of Staff and Associate Director of Education for Agudath Israel. “After speaking with infectious disease experts, we were advised that the downsides of plasma donations are minimal and, with drugs and vaccines far from development, plasma therapy seemed logical to pursue. With that, we began encouraging our eligible constituents to donate plasma on [Wednesday,] April 1.”